-
QIAGEN Nv
-
Sector
Health Care
-
Industry
Life Sciences Tools & Services
-
Company web
Link
-
Employees
Full Time Employees: 4,684
-
Executives
- Manfred Karobath
- Peer Schatz
- Roland Sackers
- Thomas Schweins
- Thierry Bernard
- Laura Furmanski
- Douglas Liu
- Manuel Mendez
- Stephane Bancel
- Hakan Bjorklund
-
Company address
- Hulsterweg 82
- Venlo, 5912 PL
- Netherlands
- 1-31 77 355 6600
-
Investor Relation Site
Link
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. It offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technology solutions. The company provides Ingenuity Variant Analysis, a cloud-based platform that interprets data from next-generation sequencing (NGS) analysis; QIAGEN Clinical Insight, an evidence-based decision support solution; CLC Genomics Workbench for the analysis and visualization of data from various NGS platforms; and GeneGlobe, a Web-based portal that enables researchers to search and select gene-and pathway-specific solutions from pre-designed and custom PCR assay kits, NGS assay panels, and other products. It also offers instrumentation systems for laboratories. The company’s automation platforms include QIAsymphony, a modular system; GeneReader NGS System, a sample to insight NGS solution for laboratories; Modaplex, a multimodal automation system; QIAcube, a sample processing instrument; EZ1 Advanced XL for automated nucleic acid purification; QIAxcel for nucleic acid separation; QIAscout that enables researchers to select and isolate viable single cells; PyroMark, a detection platform that enables real-time analysis and quantification of genetic mutations and DNA methylation patterns; QIAgility, a benchtop instrument; and ESEQuant instruments that enable optical measurement for point of need molecular testing in healthcare and other applications. It serves molecular diagnostics, applied testing, pharma, and academia customers. QIAGEN N.V. has a partnership with Bristol-Myers Squibb to develop gene expression profiles for immuno-oncology therapies. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
QIAGEN Nv: Slide deck
- QGEN - Q4 Investor Presentation Slide 22 Nov 2016: Slides deck
- QGEN - Q3 Investor Presentation Slide 15 Sep 2017: Slides deck
- QGEN - Q3 Investor Presentation Slide 23 Sep 2016: Slides deck
- QGEN - Q2 Investor Presentation Slide 2 June 2017: Slides deck
- QGEN - Q2 Investor Presentation Slide 29 April 2016: Slides deck
- QGEN - Q1 Investor Presentation Slide 22 Feb 2017: Slides deck
- QGEN - Q4 Investor Presentation Slide 12 Jan 2017: Slides deck